Navigation Links
Cancer-Causing Virus Synthesizes Protein To Help Sustain Itself In Host Cells

ruses,' says principal investigator Patrick L. Green, professor of veterinary biosciences and of molecular virology, immunology and medical genetics, and a Comprehensive Cancer Center researcher.

'Our study is the first to show that this novel protein is important for survival of the virus, which suggests that a drug that targets it might disrupt viral replication and provide a new therapy for infected people.'

Some 15 to 25 million people are infected with HTLV-1 worldwide, and 1 to 4 percent of them will eventually develop adult T-cell leukemia or lymphoma, a cancer that responds poorly to treatment and that can cause death within six months. In others, it causes a crippling and painful autoimmune-like disorder, tropical spastic paraparesis.

For this study, Green and his collaborators first looked at how loss of the HBZ protein affected the virus’s ability to infect and survive in its normal host immune cell, human T lymphocytes, or T cells, growing in culture.

They found little difference between the HBZ mutant HTLV and the normal virus. Both infected the cells and immortalized them equally well.

(Normally, T cells in culture die within a week or two. When the same cells are infected with HTLV-1, however, the virus causes changes that extend their life span indefinitely.)

Next, the scientists tested the ability of the mutant virus to infect and persist in a rabbit model, one of the few animals that duplicates human HTLV-1 infection. Those results indicated that the HBZ protein was required for prolonged infection in the body.

After eight weeks, rabbits that were infected with virus that lacked HBZ had one to 10 copies of the virus per 1,000 lymphocytes, whereas rabbits infected with normal virus had 50 to 100 HTLV-1 copies per 1,000 lymphocytes.

The virus may not survive well without HBZ because the immune system readily destroys cells infected by these viruses
'"/>




Page: 1 2 3

Related medicine news :

1. Genes That Allow Brain Cancer-Causing Stem Cells to Resist Treatment Identified
2. Virus Level could Predict Cervical Cancer Risk
3. Ebola Virus - Outbreak Claims More Lives In Uganda.
4. Experimental treatment for Ebola Virus Shows promising results in mice
5. Virus Combats Brain Tumour
6. Virus killer
7. Pain Killers Keep the Virus Away
8. Measles Suppresses AIDS Virus
9. Virus connection to cervical injury
10. Virus Helps Remove Brain Cancer
11. Origin Of SARS Virus Discovered
Post Your Comments:
(Date:8/20/2008)...r-old Contestant Wins Trip to Little League Baseba... The National Spit Tobacco Education,Program (NSTE...st today,and encouraged young baseball players to...ddiction and the health risks of using tobacco pro...year,s slogan contest winner is,Joe Reck, a nine-y...
(Date:8/20/2008)...cently enacted Medicare Improvement Law immediatel...re Advantage insurance companies .../PRNewswire/ -- When the House and Senate,overrode...gislation,protecting Medicare beneficiaries, they ...e Advantage plans during one of the busiest months...
(Date:8/20/2008)...T CREEK, Calif., Aug. 20 /PRNewswire-FirstCall/ --... reported preliminary income from,continuing opera...f $27.5,million, or $0.76 per diluted share, inclu...er diluted share, related to provisions for store,... a 6.8 percent increase,compared with income from ...
(Date:8/20/2008)...FIELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/Cha...llness Promotion will give thousands of,Detroit me...ALTHY LIVING,FOR KIDS" program. This year the prog....m. to 5 p.m. at the Charles H. Wright Museum of A...77, "Healthy Living for Kids",has provided free im...
Breaking Medicine News(10 mins):Health News:Slogan Contest Educates Young Baseball Players About the Dangers of Tobacco Use 2Health News:Medicare Advantage Plans Struggle to Comply With New Federal Law 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 3Health News:Longs Drug Stores Corporation Reports Second Quarter Results 4Health News:Longs Drug Stores Corporation Reports Second Quarter Results 5Health News:Longs Drug Stores Corporation Reports Second Quarter Results 6Health News:Longs Drug Stores Corporation Reports Second Quarter Results 7Health News:Longs Drug Stores Corporation Reports Second Quarter Results 8Health News:Longs Drug Stores Corporation Reports Second Quarter Results 9Health News:Longs Drug Stores Corporation Reports Second Quarter Results 10Health News:Longs Drug Stores Corporation Reports Second Quarter Results 11Health News:Longs Drug Stores Corporation Reports Second Quarter Results 12Health News:Longs Drug Stores Corporation Reports Second Quarter Results 13Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 3
...ernet archive for research works on medical and al...nt body, has been nominated as a finalist for the ...cked by the National Informatics Centre, OpenMED a...archive their scientific and technical documents. ...
...e visit off Hurricane Katrina, the survivors are s...d on the survivors scattered across the nation // ...hat the people are now facing problems, and suffer...the federal government has launched the biggest & ...
... Ohio-based Cleveland Clinic, to inaugrate a satel...ices which would benefit Canadians // considering ...t. The Cleveland clinic houses more than 1,900 sci... medical group in the U.S, treating pateints from ...
...markets Aricept with Pfizer Inc. Aricept is alread...te Alzheimer's disease //, but at present it was b...e second most common form of dementia after Alzhei...s show that about eleven patients have died while ...
Other Medicine News:Health News:OpenMED Nominated For Stockholm Challenge 2006 Award 2Health News:Hurricane Hangover: Katrina Still Haunts 2Health News:Hurricane Hangover: Katrina Still Haunts 3Health News:Hurricane Hangover: Katrina Still Haunts 4Health News:Satellite Clinic To Be Set Up in Toronto By Ohio-Based Cleveland Clinic 2
(Date:8/19/2008)...IEGO, Aug. 19 /- Vical Inco...ch collaboration with the Karolinska,Institute, a ...sh Institute,for Infectious Disease Control (SMI),... Vaxfectin(R) adjuvant with the Biojector(R) 2000,...nologies Inc.,OTCBB:BJCT) for a multivalent preve...
(Date:8/18/2008)...ALEM, Israel, August 18 /- ...tp://www.oramed.com ), a developer,of oral deliver...tled "Open,Label Study to Assess the Safety, Pharm... Oral Insulin Formulations in Healthy,Subjects," h...th Annual,Meeting of the European Association for ...
(Date:8/17/2008)...Y, Australia, Aug. 17 /Xinhua-PRNewswire-FirstCall...unced that the first pivotal Phase 3,clinical tria...is has,completed enrolment., The first efficacy d...ing the first half of 2009. The trial commenced it...recruitment target of 250 subjects in June,2008 an...
(Date:8/14/2008)... cell engaging antibody (BiTE) showing clinical be...ients own T cells to recognize and attack ... Aug. 14 /- Micromet, Inc.,...loping novel, proprietary,antibodies for the treat...es, today announced publication of a Phase 1 clini...
Breaking Medicine Technology:Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 2Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 3Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 4Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 5Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome) 2Bronchitol Phase 3 Cystic Fibrosis Trial Completes Recruitment 2Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 2Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 3Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 4Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 5Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 6Gynecologic Oncologist With Board Certification in GYN Oncology OB GYN and Surgery Offers Women With Cancer the Newest Treatment Frontier 3A the Su 4449 1Gynecologic Oncologist With Board Certification in GYN Oncology OB GYN and Surgery Offers Women With Cancer the Newest Treatment Frontier 3A the Su 4449 2Navigenics Proposes Standards for Personal Genomics Services Coupled With Prospective Outcomes Studies to Safeguard Consumers 16205 1Navigenics Proposes Standards for Personal Genomics Services Coupled With Prospective Outcomes Studies to Safeguard Consumers 16205 2Navigenics Proposes Standards for Personal Genomics Services Coupled With Prospective Outcomes Studies to Safeguard Consumers 16205 3Navigenics Proposes Standards for Personal Genomics Services Coupled With Prospective Outcomes Studies to Safeguard Consumers 16205 4Navigenics Proposes Standards for Personal Genomics Services Coupled With Prospective Outcomes Studies to Safeguard Consumers 16205 5Molecular Vision and Acrongenomics Unable to Reach Agreement on the Acquisition of Molecular Vision 4447 1How Patients Can Meet the Criteria for Insulin Pump Therapy 16199 1How Patients Can Meet the Criteria for Insulin Pump Therapy 16199 2How Patients Can Meet the Criteria for Insulin Pump Therapy 16199 3
...swire/ -- At the April AACR,Annual Meeting, Indivu...c basis for a new drug test-platform to predict dr...imary cell lines are currently the first,choice fo...on and,expansion, however, their gene and protein ...losing many of their primary,characteristics. Prim...
... Biogen Idec (NASDAQ: BIIB),and Elan Corporation, ... the TOUCH Prescribing Program(TM) and TYGRIS safe...clinical studies of,TYSABRI(R) (natalizumab). Also...can Academy of Neurology in Boston, MA were extens...ained treatment,effect on clinical relapses and th...
Other Medicine Technology:Indivumed Study Provides Sound Scientific Basis for a Predictive,Drug Test- Platform 2Data Presented at the American Academy of Neurology's Annual,Meeting Provide Update on Utilization and Safety of Tysabri in,Patients with Multiple Sclerosis 2Data Presented at the American Academy of Neurology's Annual,Meeting Provide Update on Utilization and Safety of Tysabri in,Patients with Multiple Sclerosis 3Data Presented at the American Academy of Neurology's Annual,Meeting Provide Update on Utilization and Safety of Tysabri in,Patients with Multiple Sclerosis 4Data Presented at the American Academy of Neurology's Annual,Meeting Provide Update on Utilization and Safety of Tysabri in,Patients with Multiple Sclerosis 5Data Presented at the American Academy of Neurology's Annual,Meeting Provide Update on Utilization and Safety of Tysabri in,Patients with Multiple Sclerosis 6
...n Through A 1.0mm Incision., ,Special Direct A...Ergonomics., ,Curved Shafts For A More Comfort...b-Incisional Flap Purchase., ,Protective Cap S...n., ,Reusable, Autoclaveable, Guaranteed For L...
The blades are actually bent to form a concave posterior surface. The result is a blade which better conforms to incising a globe at a non-perpendicular angle. The resulting incision is more pristine
...Design With Spreading Spatula Tips That Mimic Corn...g & Lifting Of Corneal Flaps Created With The Intr...ips Of The Forceps Are Designed To Facilitate Acce...d, The Cross-Action Forceps Design Allows The Surg...
...ut Foldable Silicone Lenses Through A Smaller Inci...en High Diopter Silicone Lenses With Ease With One...ertion Through A 2.6mm Phaco Incision For Explanta...ay Surgical Evaluation Without Obligation, & A Com...
Medicine Products: